Advertisement
Tai chi has a favorable effect on physical performance in four chronic conditions

Tai Chi Aids Physical Performance in Chronic Conditions

0
Improvement or tendency toward improvement in heart failure, osteoarthritis, cancer, COPD
Empagliflozin in addition to standard care is beneficial for patients with type 2 diabetes at high cardiovascular risk

Empagliflozin Plus Standard Care Beneficial in T2DM

0
Lower rate of primary composite outcome for type 2 diabetes patients at high cardiovascular risk
For cirrhotic patients with acute variceal bleeding

Beta-Blockers Don’t Mar Acute Variceal Bleeding Prognosis

0
NSBB treatment is not a negative prognostic factor for short-term survival of cirrhotic patients
Tai chi is effective in managing several hypertension-related risk factors in older adults

Tai Chi Improves BP Control, Quality of Life in Older Adults

0
But does not help with metabolic syndrome levels, dyslipidemia, hyperglycemia
Blood pressure medications may raise the risk of colorectal polyps

Risk of Colorectal Polyps Tied to Blood Pressure Medications

0
Risk increases with the number of antihypertensive drugs taken
In academic medicine

Women Less Likely to Be Full Professors Than Men

0
And male grant applicants report significantly higher startup support compared with females
Patients who are frequently admitted to U.S. academic medical centers are significantly more likely than other patients to have multiple complex chronic conditions

Complex Chronic Diseases Appear to Drive Frequent Admissions

0
1.6 percent of patients make up 8 percent of admissions, comprise 7 percent of direct costs
A chronic disease cost calculator has been developed to estimate state-level costs

CDC Develops State-Level Chronic Disease Cost Calculator

0
Calculator identifies median state-specific medical costs and median absenteeism costs
For patients with coronary artery disease on statin therapy after undergoing a first percutaneous coronary intervention

Low HDL-C, High CRP Ups Mortality for Patients With CAD

0
Findings in patients with coronary artery disease on statin therapy after undergoing first PCI
The U.S. Preventive Services Task Force has concluded that the benefits and harms of low-dose aspirin for prevention of cardiovascular disease and cancer vary by patient age. These findings form the basis of a draft recommendation statement published online Sept. 14 by the USPSTF.

USPSTF Recommendations for Aspirin Use Vary by Age

0
Recommended for some patients aged 50 to 59 years; insufficient evidence for those <50, ≥70